Head-to-head · Cost-Efficiency Index
CoreAge Rx vs Nurx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
CoreAge Rx
Anyone optimizing for real value — a transparent flat price you can model for a full year, nationwide, without a bait-and-switch.
Visit CoreAge RxNurx
Shoppers who specifically want FDA-approved brand-name Wegovy/Zepbound access through an established telehealth brand and don't want a compounded product.
Visit NurxThe verdict
CoreAge Rx takes it, leading the Cost-Efficiency Index 94 to 50. Best value in the ranking: both molecules at one flat, all-50 price with no teaser step-ups — the lowest true cost of ownership, not the lowest teaser. Nurx still earns a C — Shoppers who specifically want FDA-approved brand-name Wegovy/Zepbound access through an established telehealth brand and don't want a compounded product.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | CoreAge Rx | Nurx |
|---|---|---|
| Cost-Efficiency Index | 94/100 | 50/100 |
| Semaglutide / mo | $99/mo | $1,379/mo (brand Wegovy) |
| Tirzepatide / mo | $149/mo | $1,079/mo (brand Zepbound) |
| Semaglutide / yr (modeled) | $1,188 | $16,548 |
| Tirzepatide / yr (modeled) | $1,788 | $12,948 |
| Coverage | All 50 states | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #1 | #411 |
CoreAge Rx
94/100Where the value is
- Flat all-in monthly price — no intro rate that silently triples after month one, so the modeled annual cost is the real cost
- Both compounded semaglutide and tirzepatide on one account at published prices
- Available in all 50 states — no coverage gamble
The tradeoffs
- Not the rock-bottom sticker price — 30 of the 381 priced semaglutide programs we track list a cheaper figure, though most attach a term or a step-up that CoreAge does not
- No FDA-approved brand-name option (compounded only)
Nurx
50/100Where the value is
- Backed by Thirty Madison, an established telehealth parent company that also runs Keeps and Cove
- Prescribes genuinely FDA-approved brand-name GLP-1s (Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda, Victoza) rather than a compounded substitute
- Names two Medical Directors on its team page (Dr. Peter Young, Dr. Neil Zlatniski)
The tradeoffs
- Sells NO compounded semaglutide or tirzepatide at any price — a prior dataset's '$179/mo compounded' figure does not describe any product actually on this site
- Nurx's own advertised medication prices ($1,000-$1,300/mo) are Nurx's estimate of what the PHARMACY will charge, not a price Nurx guarantees or collects — actual cost varies by pharmacy and insurance
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.